Market Research Logo

Cancer Registry Software - Global Market Outlook (2017-2026)

Cancer Registry Software - Global Market Outlook (2017-2026)

According to Stratistics MRC, the Global Cancer Registry Software Market is accounted for $43.2 million in 2017 and is expected to reach $112.2 million by 2026 growing at a CAGR of 11.2% from 2017 to 2026. Some of the factors such as increase in prevalence of cancer and favorable government initiatives are impelling the market growth. However privacy and data security-related concerns are restricting the market growth. Increase in number of accountable care organizations is creating ample opportunities for the market growth.

Cancer Registry Software is a particular type of disease registry that is mainly used in order to establish and maintain a cancer incidence reporting system. The cancer registry system acts as an informational resource for the investigation of cancer and its causes. This type of registry is important as cancer is among the leading causes of death and therefore the collection of data on cancer cases from diagnosis through survivorship is beneficial in order to help identify trends and ultimately improve care for patients that are fighting cancer.

Based on type, the standalone software segment accounted for a larger share primarily due to the significant use of standalone software by government organizations & TPAs for population health management (due to its adaptability and interoperability). Also, standalone software provides practical and easy-to-use tools to store and process registry data, while standalone software customized for patient registries offers higher flexibility and features such as multiple system usage and automatic upgradation. Based on the geography, North America dominated the market growth due to the high burden of cancer, government funding initiatives to encourage the development of cancer registries.

Some of the key players in Cancer Registry Software market include, Onco, Inc., Rocky Mountain Cancer Data Systems, Mckesson Corporation, Elekta AB (PUB), C/Net Solutions and Electronic Registry Systems, Inc.

Types Covered:
• Integrated Software
• Standalone Software

Deployment Models Covered:
• Cloud-Based Models
• On-Premise Models

Database Types Covered:
• Commercial Databases
• Public Databases

Functionalities Covered:
• Patient Care Management
• Product Outcome Evaluation
• Cancer Reporting to Meet State and Federal Regulations
• Medical Research & Clinical Studies

End Users Covered:
• Hospitals & Medical Practices
• Government Organizations & Third-Party Administrators
• Pharmaceutical, Biotechnology, and Medical Device Companies
• Private Payers
• Research Centers
• Other End Users

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
Comprehensive profiling of additional market players (up to 3)
SWOT Analysis of key players (up to 3)
• Regional Segmentation
Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Cancer Registry Software Market, By Type
5.1 Introduction
5.2 Integrated Software
5.3 Standalone Software
6 Global Cancer Registry Software Market, By Deployment Model
6.1 Introduction
6.2 Cloud-Based Models
6.3 On-Premise Models
7 Global Cancer Registry Software Market, By Database Type
7.1 Introduction
7.2 Commercial Databases
7.3 Public Databases
8 Global Cancer Registry Software Market, By Functionality
8.1 Introduction
8.2 Patient Care Management
8.3 Product Outcome Evaluation
8.4 Cancer Reporting to Meet State and Federal Regulations
8.5 Medical Research & Clinical Studies
9 Global Cancer Registry Software Market, By End User
9.1 Introduction
9.2 Hospitals & Medical Practices
9.3 Government Organizations & Third-Party Administrators
9.4 Pharmaceutical, Biotechnology, and Medical Device Companies
9.5 Private Payers
9.6 Research Centers
9.7 Other End Users
10 Global Cancer Registry Software Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Onco, Inc.
12.2 Rocky Mountain Cancer Data Systems
12.3 Mckesson Corporation
12.4 Elekta AB (PUB)
12.5 C/Net Solutions
12.6 Electronic Registry Systems, Inc.
List of Tables
Table 1 Global Cancer Registry Software Market Outlook, By Region (2016-2026) (US $MN)
Table 2 Global Cancer Registry Software Market Outlook, By Type (2016-2026) (US $MN)
Table 3 Global Cancer Registry Software Market Outlook, By Integrated Software (2016-2026) (US $MN)
Table 4 Global Cancer Registry Software Market Outlook, By Standalone Software (2016-2026) (US $MN)
Table 5 Global Cancer Registry Software Market Outlook, By Deployment Model (2016-2026) (US $MN)
Table 6 Global Cancer Registry Software Market Outlook, By Cloud-Based Models (2016-2026) (US $MN)
Table 7 Global Cancer Registry Software Market Outlook, By On-Premise Models (2016-2026) (US $MN)
Table 8 Global Cancer Registry Software Market Outlook, By Database Type (2016-2026) (US $MN)
Table 9 Global Cancer Registry Software Market Outlook, By Commercial Databases (2016-2026) (US $MN)
Table 10 Global Cancer Registry Software Market Outlook, By Public Databases (2016-2026) (US $MN)
Table 11 Global Cancer Registry Software Market Outlook, By Functionality (2016-2026) (US $MN)
Table 12 Global Cancer Registry Software Market Outlook, By Patient Care Management (2016-2026) (US $MN)
Table 13 Global Cancer Registry Software Market Outlook, By Product Outcome Evaluation (2016-2026) (US $MN)
Table 14 Global Cancer Registry Software Market Outlook, By Cancer Reporting to Meet State and Federal Regulations (2016-2026) (US $MN)
Table 15 Global Cancer Registry Software Market Outlook, By Medical Research & Clinical Studies (2016-2026) (US $MN)
Table 16 Global Cancer Registry Software Market Outlook, By Hospitals & Medical Practices (2016-2026) (US $MN)
Table 17 Global Cancer Registry Software Market Outlook, By Government Organizations & Third-Party Administrators (2016-2026) (US $MN)
Table 18 Global Cancer Registry Software Market Outlook, By Pharmaceutical, Biotechnology, and Medical Device Companies (2016-2026) (US $MN)
Table 19 Global Cancer Registry Software Market Outlook, By Private Payers (2016-2026) (US $MN)
Table 20 Global Cancer Registry Software Market Outlook, By Research Centers (2016-2026) (US $MN)
Table 21 Global Cancer Registry Software Market Outlook, By Other End Users (2016-2026) (US $MN)
Table 22 North America Cancer Registry Software Market Outlook, By Country (2016-2026) (US $MN)
Table 23 North America Cancer Registry Software Market Outlook, By Type (2016-2026) (US $MN)
Table 24 North America Cancer Registry Software Market Outlook, By Integrated Software (2016-2026) (US $MN)
Table 25 North America Cancer Registry Software Market Outlook, By Standalone Software (2016-2026) (US $MN)
Table 26 North America Cancer Registry Software Market Outlook, By Deployment Model (2016-2026) (US $MN)
Table 27 North America Cancer Registry Software Market Outlook, By Cloud-Based Models (2016-2026) (US $MN)
Table 28 North America Cancer Registry Software Market Outlook, By On-Premise Models (2016-2026) (US $MN)
Table 29 North America Cancer Registry Software Market Outlook, By Database Type (2016-2026) (US $MN)
Table 30 North America Cancer Registry Software Market Outlook, By Commercial Databases (2016-2026) (US $MN)
Table 31 North America Cancer Registry Software Market Outlook, By Public Databases (2016-2026) (US $MN)
Table 32 North America Cancer Registry Software Market Outlook, By Functionality (2016-2026) (US $MN)
Table 33 North America Cancer Registry Software Market Outlook, By Patient Care Management (2016-2026) (US $MN)
Table 34 North America Cancer Registry Software Market Outlook, By Product Outcome Evaluation (2016-2026) (US $MN)
Table 35 North America Cancer Registry Software Market Outlook, By Cancer Reporting to Meet State and Federal Regulations (2016-2026) (US $MN)
Table 36 North America Cancer Registry Software Market Outlook, By Medical Research & Clinical Studies (2016-2026) (US $MN)
Table 37 North America Cancer Registry Software Market Outlook, By Hospitals & Medical Practices (2016-2026) (US $MN)
Table 38 North America Cancer Registry Software Market Outlook, By Government Organizations & Third-Party Administrators (2016-2026) (US $MN)
Table 39 North America Cancer Registry Software Market Outlook, By Pharmaceutical, Biotechnology, and Medical Device Companies (2016-2026) (US $MN)
Table 40 North America Cancer Registry Software Market Outlook, By Private Payers (2016-2026) (US $MN)
Table 41 North America Cancer Registry Software Market Outlook, By Research Centers (2016-2026) (US $MN)
Table 42 North America Cancer Registry Software Market Outlook, By Other End Users (2016-2026) (US $MN)
Table 43 Europe Cancer Registry Software Market Outlook, By Country (2016-2026) (US $MN)
Table 44 Europe Cancer Registry Software Market Outlook, By Type (2016-2026) (US $MN)
Table 45 Europe Cancer Registry Software Market Outlook, By Integrated Software (2016-2026) (US $MN)
Table 46 Europe Cancer Registry Software Market Outlook, By Standalone Software (2016-2026) (US $MN)
Table 47 Europe Cancer Registry Software Market Outlook, By Deployment Model (2016-2026) (US $MN)
Table 48 Europe Cancer Registry Software Market Outlook, By Cloud-Based Models (2016-2026) (US $MN)
Table 49 Europe Cancer Registry Software Market Outlook, By On-Premise Models (2016-2026) (US $MN)
Table 50 Europe Cancer Registry Software Market Outlook, By Database Type (2016-2026) (US $MN)
Table 51 Europe Cancer Registry Software Market Outlook, By Commercial Databases (2016-2026) (US $MN)
Table 52 Europe Cancer Registry Software Market Outlook, By Public Databases (2016-2026) (US $MN)
Table 53 Europe Cancer Registry Software Market Outlook, By Functionality (2016-2026) (US $MN)
Table 54 Europe Cancer Registry Software Market Outlook, By Patient Care Management (2016-2026) (US $MN)
Table 55 Europe Cancer Registry Software Market Outlook, By Product Outcome Evaluation (2016-2026) (US $MN)
Table 56 Europe Cancer Registry Software Market Outlook, By Cancer Reporting to Meet State and Federal Regulations (2016-2026) (US $MN)
Table 57 Europe Cancer Registry Software Market Outlook, By Medical Research & Clinical Studies (2016-2026) (US $MN)
Table 58 Europe Cancer Registry Software Market Outlook, By Hospitals & Medical Practices (2016-2026) (US $MN)
Table 59 Europe Cancer Registry Software Market Outlook, By Government Organizations & Third-Party Administrators (2016-2026) (US $MN)
Table 60 Europe Cancer Registry Software Market Outlook, By Pharmaceutical, Biotechnology, and Medical Device Companies (2016-2026) (US $MN)
Table 61 Europe Cancer Registry Software Market Outlook, By Private Payers (2016-2026) (US $MN)
Table 62 Europe Cancer Registry Software Market Outlook, By Research Centers (2016-2026) (US $MN)
Table 63 Europe Cancer Registry Software Market Outlook, By Other End Users (2016-2026) (US $MN)
Table 64 Asia Pacific Cancer Registry Software Market Outlook, By Country (2016-2026) (US $MN)
Table 65 Asia Pacific Cancer Registry Software Market Outlook, By Type (2016-2026) (US $MN)
Table 66 Asia Pacific Cancer Registry Software Market Outlook, By Integrated Software (2016-2026) (US $MN)
Table 67 Asia Pacific Cancer Registry Software Market Outlook, By Standalone Software (2016-2026) (US $MN)
Table 68 Asia Pacific Cancer Registry Software Market Outlook, By Deployment Model (2016-2026) (US $MN)
Table 69 Asia Pacific Cancer Registry Software Market Outlook, By Cloud-Based Models (2016-2026) (US $MN)
Table 70 Asia Pacific Cancer Registry Software Market Outlook, By On-Premise Models (2016-2026) (US $MN)
Table 71 Asia Pacific Cancer Registry Software Market Outlook, By Database Type (2016-2026) (US $MN)
Table 72 Asia Pacific Cancer Registry Software Market Outlook, By Commercial Databases (2016-2026) (US $MN)
Table 73 Asia Pacific Cancer Registry Software Market Outlook, By Public Databases (2016-2026) (US $MN)
Table 74 Asia Pacific Cancer Registry Software Market Outlook, By Functionality (2016-2026) (US $MN)
Table 75 Asia Pacific Cancer Registry Software Market Outlook, By Patient Care Management (2016-2026) (US $MN)
Table 76 Asia Pacific Cancer Registry Software Market Outlook, By Product Outcome Evaluation (2016-2026) (US $MN)
Table 77 Asia Pacific Cancer Registry Software Market Outlook, By Cancer Reporting to Meet State and Federal Regulations (2016-2026) (US $MN)
Table 78 Asia Pacific Cancer Registry Software Market Outlook, By Medical Research & Clinical Studies (2016-2026) (US $MN)
Table 79 Asia Pacific Cancer Registry Software Market Outlook, By Hospitals & Medical Practices (2016-2026) (US $MN)
Table 80 Asia Pacific Cancer Registry Software Market Outlook, By Government Organizations & Third-Party Administrators (2016-2026) (US $MN)
Table 81 Asia Pacific Cancer Registry Software Market Outlook, By Pharmaceutical, Biotechnology, and Medical Device Companies (2016-2026) (US $MN)
Table 82 Asia Pacific Cancer Registry Software Market Outlook, By Private Payers (2016-2026) (US $MN)
Table 83 Asia Pacific Cancer Registry Software Market Outlook, By Research Centers (2016-2026) (US $MN)
Table 84 Asia Pacific Cancer Registry Software Market Outlook, By Other End Users (2016-2026) (US $MN)
Table 85 South America Cancer Registry Software Market Outlook, By Country (2016-2026) (US $MN)
Table 86 South America Cancer Registry Software Market Outlook, By Type (2016-2026) (US $MN)
Table 87 South America Cancer Registry Software Market Outlook, By Integrated Software (2016-2026) (US $MN)
Table 88 South America Cancer Registry Software Market Outlook, By Standalone Software (2016-2026) (US $MN)
Table 89 South America Cancer Registry Software Market Outlook, By Deployment Model (2016-2026) (US $MN)
Table 90 South America Cancer Registry Software Market Outlook, By Cloud-Based Models (2016-2026) (US $MN)
Table 91 South America Cancer Registry Software Market Outlook, By On-Premise Models (2016-2026) (US $MN)
Table 92 South America Cancer Registry Software Market Outlook, By Database Type (2016-2026) (US $MN)
Table 93 South America Cancer Registry Software Market Outlook, By Commercial Databases (2016-2026) (US $MN)
Table 94 South America Cancer Registry Software Market Outlook, By Public Databases (2016-2026) (US $MN)
Table 95 South America Cancer Registry Software Market Outlook, By Functionality (2016-2026) (US $MN)
Table 96 South America Cancer Registry Software Market Outlook, By Patient Care Management (2016-2026) (US $MN)
Table 97 South America Cancer Registry Software Market Outlook, By Product Outcome Evaluation (2016-2026) (US $MN)
Table 98 South America Cancer Registry Software Market Outlook, By Cancer Reporting to Meet State and Federal Regulations (2016-2026) (US $MN)
Table 99 South America Cancer Registry Software Market Outlook, By Medical Research & Clinical Studies (2016-2026) (US $MN)
Table 100 South America Cancer Registry Software Market Outlook, By Hospitals & Medical Practices (2016-2026) (US $MN)
Table 101 South America Cancer Registry Software Market Outlook, By Government Organizations & Third-Party Administrators (2016-2026) (US $MN)
Table 102 South America Cancer Registry Software Market Outlook, By Pharmaceutical, Biotechnology, and Medical Device Companies (2016-2026) (US $MN)
Table 103 South America Cancer Registry Software Market Outlook, By Private Payers (2016-2026) (US $MN)
Table 104 South America Cancer Registry Software Market Outlook, By Research Centers (2016-2026) (US $MN)
Table 105 South America Cancer Registry Software Market Outlook, By Other End Users (2016-2026) (US $MN)
Table 106 Middle East & Africa Cancer Registry Software Market Outlook, By Country (2016-2026) (US $MN)
Table 107 Middle East & Africa Cancer Registry Software Market Outlook, By Type (2016-2026) (US $MN)
Table 108 Middle East & Africa Cancer Registry Software Market Outlook, By Integrated Software (2016-2026) (US $MN)
Table 109 Middle East & Africa Cancer Registry Software Market Outlook, By Standalone Software (2016-2026) (US $MN)
Table 110 Middle East & Africa Cancer Registry Software Market Outlook, By Deployment Model (2016-2026) (US $MN)
Table 111 Middle East & Africa Cancer Registry Software Market Outlook, By Cloud-Based Models (2016-2026) (US $MN)
Table 112 Middle East & Africa Cancer Registry Software Market Outlook, By On-Premise Models (2016-2026) (US $MN)
Table 113 Middle East & Africa Cancer Registry Software Market Outlook, By Database Type (2016-2026) (US $MN)
Table 114 Middle East & Africa Cancer Registry Software Market Outlook, By Commercial Databases (2016-2026) (US $MN)
Table 115 Middle East & Africa Cancer Registry Software Market Outlook, By Public Databases (2016-2026) (US $MN)
Table 116 Middle East & Africa Cancer Registry Software Market Outlook, By Functionality (2016-2026) (US $MN)
Table 117 Middle East & Africa Cancer Registry Software Market Outlook, By Patient Care Management (2016-2026) (US $MN)
Table 118 Middle East & Africa Cancer Registry Software Market Outlook, By Product Outcome Evaluation (2016-2026) (US $MN)
Table 119 Middle East & Africa Cancer Registry Software Market Outlook, By Cancer Reporting to Meet State and Federal Regulations (2016-2026) (US $MN)
Table 120 Middle East & Africa Cancer Registry Software Market Outlook, By Medical Research & Clinical Studies (2016-2026) (US $MN)
Table 121 Middle East & Africa Cancer Registry Software Market Outlook, By Hospitals & Medical Practices (2016-2026) (US $MN)
Table 122 Middle East & Africa Cancer Registry Software Market Outlook, By Government Organizations & Third-Party Administrators (2016-2026) (US $MN)
Table 123 Middle East & Africa Cancer Registry Software Market Outlook, By Pharmaceutical, Biotechnology, and Medical Device Companies (2016-2026) (US $MN)
Table 124 Middle East & Africa Cancer Registry Software Market Outlook, By Private Payers (2016-2026) (US $MN)
Table 125 Middle East & Africa Cancer Registry Software Market Outlook, By Research Centers (2016-2026) (US $MN)
Table 126 Middle East & Africa Cancer Registry Software Market Outlook, By Other End Users (2016-2026) (US $MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report